StephanBusqueMD

General Surgery • Stanford, CA

Transplantation

Professor, Surgery - Multi-Organ Transplantation, Stanford University Medical Center

Join to view full profile

Dr. Busque is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Busque's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

University of Montreal Faculty of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1993 - 2026
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
Completed
Phase 4
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
Active, not recruiting
Phase 1, Phase 2
Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors Start of enrollment: 2003 Mar 01
Completed
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14
Active, not recruiting
Phase 1
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation Start of enrollment: 2017 Feb 14
Recruiting
Early Phase 1
Roles: Principal Investigator
TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation Start of enrollment: 2020 Feb 01
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs. Start of enrollment: 2018 Sep 13
Recruiting
Phase 1
Roles: Principal Investigator, Contact, Sponsor-Investigator
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy Start of enrollment: 2023 Oct 01
Not yet recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance.
Helen Stark, Quan Yao Ho, Amy Cross, Alessandro Alessandrini, Alice Bertaina
Transplantation. 2025-04-01
Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF).
Sangeeta Kowli, Sheroy Minocherhomji, Olivia M Martinez, Stephan Busque, Herve Lebrec
Immunohorizons. 2025-02-18
1 citations
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trial.
Dixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, James B Piper, A Osama Gaber
American Journal of Transplantation. 2025-02-06

Journal Articles

Review Macrochimerism and Clinical Transplant Tolerance
Samuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect

Press Mentions

Medeor Therapeutics to Provide Interim Results of Phase 3 Mercury Study of MDR-101 Cell Therapy in Living Donor Kidney Transplants During Rapid Fire Oral Presentation at ATC Virtual CongressMay 20th, 2021
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017